CN Stock MarketDetailed Quotes

Tasly Pharmaceutical Group (600535)

Watchlist
  • 14.64
  • -0.14-0.95%
Market Closed May 15 15:00 CST
21.87BMarket Cap18.84P/E (TTM)

Tasly Pharmaceutical Group (600535) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry7.38B89.62%
Pharmaceutical commerce765.76M9.30%
Other business89.1M1.08%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry7.38B89.62%
Pharmaceutical commerce765.76M9.30%
Other business89.1M1.08%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Tianjin13.76B167.08%
Liaoning Province815.98M9.91%
Jiangsu Province751.7M9.13%
Shandong Province259.66M3.15%
Shanghai191.5M2.32%
Other133.54M1.62%
Shaanxi Province95.91M1.16%
Other business89.1M1.08%
Offset-7.86B-95.46%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More